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Topical Application of a Novel, Hydrophilic
c-Tocopherol Derivative Reduces
Photo-Inflammation in Mice Skin
Emiko Yoshida1, Tatsuya Watanabe1, Jiro Takata2, Akihiko Yamazaki2, Yoshiharu Karube2 and
Shizuko Kobayashi1
We previously demonstrated that a novel hydrophilic g-tocopherol (g-Toc) derivative, g-tocopherol-N,
N-dimethylglycinate hydrochloride (g-TDMG) converts to g-Toc in the mouse skin and has a higher
bioavailability than g-Toc itself. In the present study, we determined whether g-TDMG could reduce photo-
inflammation in mouse skin, and compared its effectiveness to that of a-Toc acetate (a-TA). Topical pre- or post-
application of 5% g-TDMG significantly reduced the formation of edema and tempered the increase in
cyclooxygenase-2 (COX-2)-catalyzed synthesis of prostaglandin E2 (PGE2) that were induced by a single dose of
UV irradiation of 2 kJ/m2 (290–380 nm, maximum 312 nm). The pre-treatment of mouse skin with 10% a-TA had the
same anti-inflammatory effect as did g-TDMG. In spite of same having the ability to reduce PGE2 levels, the effect
of g-TDMG pre-treatment on the inhibition of COX-2 mRNA/protein expression was less than that seen with 10%
a-TA. In contrast, the increase in COX-2 activity seen after UV exposure was reduced more by g-TDMG than by
a-TA, suggesting that the reduction in PGE2 levels might have been due to the direct inhibition of COX-2 activity
by g-TDMG-derived g-Toc. Both Toc derivatives strongly suppressed inducible nitric oxide synthase (iNOS)
mRNA expression and nitric oxide (NO) production, both of which play important roles in UV-induced
inflammation. Both derivatives also significantly reduced lipid peroxidation in response to UV exposure, though
g-TDMG’s ability in this regard was less than that seen with a-TA, which correlated with their abilities to suppress
COX-2 expression. Thus, the g-TDMG-derived g-Toc acts as an antioxidant, suppresses iNOS expression and
directly inhibits COX-2 activity, all of which likely play a role in mediating its suppressive effects on photo-
inflammation. Our data further suggest that the topical application of g-TDMG, a novel hydrophilic g-Toc
derivative, may be efficacious in preventing and reducing UV-induced inflammation in humans.
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INTRODUCTION
Exposure of the skin to UV radiation induces a variety of biologic
effects including inflammation, characterized by immuno-
suppression and erythema/edema (Hruza and Pentland,
1993), the latter of which is primarily mediated by
prostaglandin E2 (PGE2) and is the most prominent visible
sign of UV-induced inflammation in human skin (Miller et al.,
1994; Buckman et al., 1998; Wilgus et al., 2000; Wilgus
et al., 2002). Increased production of PGE2 in response to UV
exposure was reported to be due to enhanced expression of
cyclooxygenase-2 (COX-2) in the epidermis (Hla and
Neilson, 1992; Grewe et al., 1993; Pentland, 1994; Buckman
et al., 1998; Isoherranen et al., 1999). The importance of
nitric oxide (NO) as a mediator of skin inflammation was
confirmed by the demonstration that UVB exposure increased
the expression of inducible nitric oxide synthase (iNOS)
mRNA and NO itself in human keratinocytes (Chang et al.,
2003). Both NO and PGE2 were shown to play roles as
secondary messengers in the inflammatory signaling cascade
(Notoya et al., 2000).
Tocopherol, a class of fat-soluble phenolic compounds
with varying degrees of vitamin E antioxidant activity, exists
as four homologous, that is, a, b, g, and d, which differ in
the number and position of methyl groups in their chroman
ring. It is generally been assumed that a-tocopherol (a-Toc)
is the most biologically active lipophilic antioxidant in many
biological systems (Traber and Sies, 1996). Topical applica-
tion of a-Toc was shown to inhibit the proliferation of UVB-
induced tumors (Gensler and Magdaleno, 1991), edema,
erythema, and lipid peroxidation (Trevithick et al., 1992);
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it was also reported to block UV-induced oxidative skin
damage. It has been suggested that g-tocopherol (g-Toc) might
have more than just antioxidant effects. Specifically,
g-Toc was found to be superior to a-Toc in its ability to
scavenge nitrogen oxides, which are mutagenic electrophiles
that are generated during inflammation (Cooney et al., 1993;
Cooney et al., 1995; Christen et al., 1997; Hoglen et al.,
1997). g-Toc is efficiently metabolized to g-carboxyethyl-
hydroxychromans (g-CEHC), the latter of which was shown
to exhibit natriuretic activity (Wechter et al., 1996; Kantoci
et al., 1997; Murray et al., 1997). g-Toc and its major
metabolite were recently shown to reduce PGE2 levels
in vitro (Jiang et al., 2000) and in vivo (Jiang et al., 2002;
Jiang and Ames, 2003), suggesting that it acts as an anti-
inflammatory agent.
g-Toc is nearly insoluble in water and is readily oxidized
by atmospheric oxygen. The phenolic functional group in
g-Toc is readily esterified and some of these ester derivatives
were shown to have improved water solubility and resistance
to oxidation. g-tocopheryl-dimethyl-glycinate (g-TDMG), the
N,N-dimethylglycine ester of g-Toc, was found to be water
soluble and hydrolyzable by esterases in rat and human liver
microsomes (Takata et al., 2002). We previously demon-
strated that topically applied g-TDMG suppressed UV-
induced erythema/edema formation in mouse skin and
displayed more tissue availability than g-Toc (Yasuoka
et al., 2005).
In this study, we demonstrated that topically applied
g-TDMG could suppress UV-induced inflammation in skin
and also examined its mechanism of action.
RESULTS
Changes of the concentrations of cutaneous c- and a-Toc after
5% c-TDMG- or 10% a-Toc acetate (a-TA)-treatment,
respectively, in mice
A 5% solution of g-TDMG or 10% a-TA was topically applied
and left on mouse skin for 1 hour, after which the solutions
were removed with 70% ethanol. Our results showed
that such treatment increased cutaneous g-Toc levels by
approximately 32 mM after 1 hour, which represented a 15-
fold increase in endogenous levels, and reached 80 mM
24 hours later (Table 1). a-Toc levels rose to similar levels
(92 mM) when 10% a-TA was used. The fact that 5% g-TDMG-
and 10% a-TA-treated skins contained the same concentra-
tions of g-Toc and a-Toc, respectively, validated our
assessment of the effects of these compounds on parameters
of inflammation.
Protective effects of 5% c-TDMG and 10% a-TA on
UV-induced edema/inflammation
Dorsal skin samples that were exposed to UV irradiation
displayed a 1.5-fold increase in thickness compared to non-
exposed skin after 24 hours. Pretreatment of the skin with
5% g-TDMG or 10% a-TA significantly suppressed this
UV-induced edema (Figure 1). In post-treated skin, g-TDMG
similarly had the ability to suppress edema though a-TA
did not.
Inhibition of UV-induced production of PGE2 by tocopherol
derivatives
In light of the suppression of UV-induced edema by g-TDMG,
we measured the amount of PGE2, a primary mediator
of inflammation, in UV-exposed mouse dorsal skin after
24 hours by enzyme immunoassay. PGE2 levels in the
exposed skin were approximately twice (14575 pg/mg
protein) those seen in non-exposed skin (8279 pg/mg
protein). As shown in Figure 2, this increase in UV-induced
PGE2 levels was significantly reduced by pretreatment with
g-TDMG, a-TA, or indomethacin. Post-treatment with
g-TDMG, but not a-TA, also significantly reduced PGE2 levels.
Table 1. Levels of cutaneous a- and c-Toc in mice after
a-TA- or c-TDMG treatment
(nmol/g wet weight)
Normal 5% c-TDMG 10% a-TA
g-Toc after
0 hour 1.970.3 32.074.9
24 hours 80.8713.8
a-Toc after
0 hour 6.370.7 32.976.8
24 hours 92.4716.8
Abbreviations: g-TDMG: g-tocopherol-N,N-dimethylglycinate hydro-
chloride; g-Toc: g-tocopherol; a-Toc: a-tocopherol.
A 5% solution of g-TDMG or 10% a-TA was topically applied to the dorsal
skin of mice and left on for 1 hour, after which the solutions were removed
with 70% ethanol. After 0 hour and 24 hours, the concentrations of g-Toc
and a-Toc were determined by HPLC. Each number represents the
means7SE of six animals.
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Figure 1. Effects of topically applied c-TDMG and a-TA on edema/
inflammation induced by UV irradiation. g-TDMG (5%) and a-TA (10%)
were topically applied to and left on, the dorsal skin for 1 hour before
(pretreatment) or after (post-treatment) UV-exposure (2 kJ/m2). The skin
samples were removed and their thickness measured 48 hours later. Each bar
represents the mean7SE of 12 skin samples from six mice. *Po0.01 relative
to irradiated; **Po0.05 relative to irradiated.
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Effects of c-TDMG and a-TA on UV-induced COX-2 mRNA/
protein expression
Since COX-2 catalyzes the synthesis of PGE2, we measured
its mRNA/protein expression by RT-PCR assay and Western
blotting, respectively. The expressions of COX-2 mRNA
(Figure 3a) and protein (Figure 3b) in UV-exposed skin were
approximately 10-fold greater than in non-exposed skin.
Pretreatments of the skin with g-TDMG and a-TA significantly
suppressed COX-2 mRNA/protein expression by 30 and 50%
of the irradiated control, respectively. Although g-TDMG had
the same ability to reduce PGE2 levels as did a-TA (Figure 2),
it was less effective in inhibiting COX-2 expression (Figures
3a and b).
Effects of tocopherol derivatives on COX-2 enzyme activity
COX-2 activity increased by 5-fold in irradiated skin
(Figure 4). This increase was significantly reduced by 60,
40, and 85% in samples that were pretreated with g-TDMG,
a-TA, or indomethacin, respectively; thus, g-TDMG was more
effective than a-TA at inhibiting COX-2 activity, in spite
of being less effective in inhibiting COX-2 gene/protein
expression.
Effects of tocopherol derivatives on iNOS mRNA expression and
generation of nitrite in UV-exposed skin
Because NO acts as a messenger in the inflammatory
cascade, 24 hours after UV irradiation, iNOS mRNA expres-
sion and NO levels were determined in the mouse skin
samples. UV exposure led to a marked increases in iNOS
mRNA levels (Figure 5a); g-TDMG and a-TA strongly
suppressed this expression. The generation of NO was
indirectly measured by quantifying nitrite formation (Figure
5b). NO production in UV-exposed skin was approxi-
mately four times that in non-exposed skin, and its produc-
tion was significantly reduced by pretreatment with g-TDMG
or a-TA.
Protective effects of c-TDMG, a-TA, and indomethacin on
UV-induced lipid peroxidation
The concentration of cutaneous thiobarbituric acid reactive
substance in irradiated skin was twice (26.2575.6 nmol/mg
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Figure 2. Inhibition of UV-induced PGE2 production by tocopherol
derivatives. Effects of pre- and post-treatment with 5% g-TDMG, 10% a-TA,
or 5% indomethacin on PGE2 levels in skin 24 hours after UV exposure. PGE2
levels are expressed as a percentage of its concentration in irradiated,
non-treated skin. Each bar represents the mean7SE of 12 skin samples from
six mice. *Po0.01 relative to irradiated.
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Figure 3. Effect of tocopherol derivatives on UV-induced COX-2 expression.
(a) Skin samples were removed 8 hours after UV exposure. Total RNA was
extracted from skin samples that were the treated with g-TDMG or a-TA for
1 hour and then irradiated. COX-2 mRNA levels were analyzed by RT-PCR
method using a specific COX-2 mRNA primer, and mRNA levels were
normalized to that of glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Lane 1, normal; lane2, irradiated; lane 3, 5% g-TDMG treated, irradiated;
lane 4, 10% a-TA treated, irradiated; lane 5, 5% indomethacin treated,
irradiated. The bars represent the relative levels of the COX-2 PCR band
compared to GAPDH; values were obtained using a densitometer. (b) The
skin samples (200 mg wet weight) that were treated with Toc derivatives were
removed 24 hours after UV exposure, frozen and then crushed in a mortar on
dry ice. The lysates (40mg protein per lane) were used for Western blotting.
Lane 1, normal; lane2, irradiated; lane 3, 5% g-TDMG treated, irradiated;
lane 4, 10% a-TA treated, irradiated; lane 5, 5% indomethacin treated,
irradiated. The bars represent the relative levels of the COX-2 blotting band
compared to b-actin; values were obtained using a densitometer. Each bar
represents the mean7SE of three experiments. *Po0.01 relative to irradiated;
**Po0.05 relative to irradiated.
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Figure 4. Inhibition of COX-2 activity by c-TDMG or a-TA treatment.
(a) g-TDMG, a-TA, and indomethacin pretreated skins were frozen in liquid
nitrogen, crushed and homogenized in 100 mM Tris-HCl buffer, pH7.5,
24 hours after being irradiated. After centrifugation, the supernatants were
assayed using a COX-2 assay kit as described in Materials and Methods. Each
bar represents the mean7SE of 12 skin samples from six mice. *Po0.01
relative to irradiated.
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protein) that found in non-irradiated skin (12.872.7 nmol/mg
protein). This increase was significantly inhibited by pretreat-
ment with g-TDMG, a-TA, or indomethacin. The relative inhi-
bition by these substances was a-TA4g-TDMG4indomethacin;
thus, a-TA appeared to be more effective than g-TDMG in
scavenging reactive oxygen species (ROS) (Figure 6).
DISCUSSION
Our data showed that the topical application of the novel,
hydrophilic g-Toc derivative, 5% g-TDMG before or after
irradiation significantly prevented edema/inflammation in-
duced by exposure to a single dose of UV irradiation. Post-
treatment with g-TDMG was also effective. While a-TA also
afforded protection when it was applied before irradiation, it
was not effective when given after irradiation. These results
suggest that the anti-inflammatory effects of g-TDMG might
not be wholly attributable to its ability to scavenge UV-
generated ROS or to have a sunscreening effect.
It was recently reported that PGE2 plays a role in
modulating signal transduction in the inflammatory pathway.
The UV exposure of skin has been shown to induce the
synthesis of PGs (Grewe et al., 1993; Buckman et al., 1998).
We demonstrated that both pre- and post-treatments with
g-TDMG significantly suppressed UV-induced PGE2 produc-
tion, supporting the notion that the suppression of UV-
induced inflammation by our test compounds was due to the
suppression of PGE2. COX-2 protein levels increased after
UVB exposure in the skins of both humans (Buckman et al.,
1998) and mice (Athar et al., 2001). Since COX-2 is one of
the key enzymes required for the synthesis of PGE2 from
arachidonic acid (Smith et al., 1996), we investigated the
effects of g-TDMG on COX-2 mRNA/protein expression in
irradiated skin. In spite of their similar abilities to suppress
PGE2 levels and the greater inhibition of COX-2 activity by
g-TDMG, the latter was less effective in suppressing COX-2
expression than a-TA. It is thought that direct inhibition of
COX-2 activity plays a role in mediating the anti-inflamma-
tory effects of g-TDMG-derived g-Toc. Jiang et al. (2000)
found that g-Toc and its major metabolite, g-CEHC, sup-
pressed PGE2 synthesis in both lipopolysaccharide-stimulated
macrophages and IL-1b-treated human epithelial cells; our
data support their findings. When 5% g-TDMG was applied
to mouse skin for 1 hour, cutaneous g-Toc levels increased by
30-fold, though g-CEHC levels remained unchanged (data not
shown). Furthermore, g-CEHC levels did not correlate with
COX-2 inhibition in mouse skin. It is theorized that g-TDMG-
derived g-Toc acts as an antioxidant and inhibitor of
COX-2 activity in skin. However, it is not clear whether
g-Toc derivative in itself, or g-TDMG is responsible for
mediating this effect.
NO is known to play a major role in UVA- (Suschek et al.,
2001) and UVB- (Suschek et al., 2004) induced inflammation
in human skin. NO production was reported to correlate with
the expression of iNOS mRNA in keratinocytes (Seo et al.,
2002). Jiang et al. (2000) reported that g-Toc and a-Toc
suppressed iNOS mRNA expression in lipopolysaccharide-
treated macrophages. Moreover, they demonstrated that high
doses (100 mg/kg) of g-Toc, but not a-Toc, reduced total
nitrite and nitrate levels in a rat inflammation model (Jiang
and Ames, 2003). We showed that both Toc derivatives, that
is, g-TDMG and a-TA, significantly inhibited the UV-induced
iNOS mRNA expression and NO production in mouse
skin. While several studies suggested the presence of a link
between the iNOS and COX pathways, the data in the
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Figure 5. Effects of c-TDMG, a-TA, and indomethacin on UV-induced iNOS
mRNA expression and nitrite production. (a) Total RNA was extracted from
the g-TDMG, a-TA, and indomethacin treated, irradiated skins. iNOS mRNA
levels were analyzed using RT-PCR and normalized to glyceraldehyde-3-
phosphate dehydrogenase (GAPDH). Lane 1, normal; lane 2, irradiated; lanes
3 and 4, 5% g-TDMG treated, irradiated; lane 5, 10% a-TA treated, irradiated;
lane 6, 5% indomethacin treated, irradiated. The bars represent the relative
levels of iNOS compared to GAPDH, as determined by densitometry.
(b) g-TDMG-, a-TA-, and indomethacin-treated, irradiated skins were
homogenized and centrifuged, and their nitrite concentration determined in
their supernatants using the fluorometric DAN test kit. Each bar represents the
mean7SE of three experiments. *Po0.01 relative to irradiated, **Po0.05
relative to irradiated.
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Figure 6. Effects of topically applied c-TDMG and a-TA on lipid peroxidation
induced by UV-exposure. Each derivative as well as indomethacin was
topically applied to the dorsal skin 1 hour before UV exposure; the skin
samples were then assayed 24 hours later. Each bar represents the mean7SE
of three experiments. *Po0.01 relative to irradiated, **Po0.05 relative to
irradiated.
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literature have been conflicting (Di Rosa et al., 1996;
Salvemini, 1997; Clancy et al., 2000). Stimulation of a wide
variety of cell types with cytokines upregulates their COX-2
expression, which is often accompanied by an increase in
iNOS levels (Vane et al., 1994; Akarasereenont et al., 1995).
Since g-TDMG did not have a strong effect on COX-2
expression, it is likely that g-TDMG-derived g-Toc was
responsible for inhibiting iNOS expression. Thus, g-TDMG-
derived g-Toc may act as an anti-inflammatory agent by
directly inhibiting COX-2 activity, suppressing iNOS expres-
sion and scavenging ROS generated by UV exposure.
It is known that UV irradiation increases cellular ROS
levels, resulting in damage to lipids, protein and DNA
(Scharffetter-Kochanek et al., 1997; Podda et al., 1998). It is
generally assumed that a-Toc is the most biological active
lipophilic antioxidant in many biological systems (Traber
and Sies, 1996). In our experiment, although both deriva-
tives-treated skins contained similar amounts of Toc, the a-TA
more prevented lipid peroxidation (50% of irradiated control)
more than did g-TDMG (30% of irradiated control). Thus,
a-TDMG-derived a-Toc probably plays an important ROS
scavenging role in response to UV exposure, suggesting that
this may have been the mechanism by which a-Toc reduced
photo-inflammation.
Our data showed that g-TDMG was more effective than
a-TA in preventing photo-inflammation, despite the fact that
both of these compounds led to the accumulation of the same
levels of intracellular Toc. We previously reported (Yasuoka
et al., 2005) that the topical application of 5% g-TDMG
significantly prevented such parameters of UV-induced
mouse skin damage as sunburn cell formation, lipid per-
oxidation and edema compared to a-TA. Since g-Toc acts as
both an antioxidant and an inhibitor of COX-2, and iNOS
expression, it stands to reason that g-TDMG might be a more
effective antiphoto-inflammation agent than a-TA. This
contention is supported by the fact that g-TDMG increased
skin g-Toc levels seven times more than did g-Toc itself even
after 24 hours after administration (Yasuoka et al., 2005).
When applied either before or after irradiation, g-TDMG
significantly prevented inflammation. It remains to be seen
whether g-TDMG is more effective in preventing photo-
inflammation than non-steroidal anti-inflammatory drugs
such as aspirin or indomethacin.
In conclusions, our data suggest that the topical applica-
tion of g-TDMG, a novel hydrophilic derivative of g-Toc,
significantly inhibits increases of PGE2 and NO production,
as well as inflammation. In this regard, the effectiveness of
g-TDMG was greater than that of a-TA.
MATERIALS AND METHODS
Chemicals
g-TDMG was kindly provided by the Showa Denko Company (Tokyo,
Japan). d-Toc and a-TA were purchased from Eizai Co. Ltd. (Tokyo,
Japan) and Sigma-Aldrich Fine Chemicals (St Louis, MO), respectively.
Animals
Female, hairless mice (5 weeks old) (SKH-hr1; Sankyo Laboservice
Inc., Tokyo, Japan) were used in this study. The mice were housed
under standard conditions (fluorescent light 12 hours/day with a
room temperature of 231C and a relative humidity of 45–55%) and
were fed a commercial diet and water ad libitum. The protocols for
all of the animal experiments were approved by the Committee for
the Ethical Use of Animals in Experiments at the Kyoritsu University
of Pharmacy.
Topical application of the tocopherol derivatives and UV
irradiation
The mice were divided into five groups of six mice each. Group 1
was left untreated; group 2 was not treated with derivatives, but was
irradiated; groups 3–5 were treated with test compounds and were
irradiated mice. Results were confirmed in duplicate experiments.
The test compounds, that is, g-TDMG and indomethacin were
separately dissolved in a water:propylene glycol:ethanol solution
(2:1:2) to make a 5% solution. a-Toc was dissolved in the same
diluents to make a 10% solution. Each of these solutions (60 ml) were
applied to a 2 4 cm2 patch of dorsal skin; mice were irradiated
either 1 hour after or before application. Control mice received
vehicle alone. The area of skin to which Toc derivatives were
applied was wiped with 70% alcohol before or 1 hour after. Skin was
exposed to a irradiation dose of 2 kJ/m2 from directly above at a
distance of 50 cm using a UV lamp (290–380 nm, maximum 312 nm,
ATTO Co., Tokyo, Japan); UV doses were determined with an Atto
Radiometer (ATR, Atto Co., Tokyo, Japan) that had a maximum
sensitivity of 312 nm. Approximately 64% of the radiation was
emitted in the range of 291–320 nm, with the rest being emitted in
the 321–380 nm range. Exposure time was 30 minutes (2 kJ/m2), and
no heat was detectable during irradiation. Animals were irradiated
while housed in stainless-steel cages that were 20 15 4.5 cm3
(six mice/cage). Irradiated skins were collected 24–48 hours after
exposure.
Skin thickness
Skin samples from six animals in each group that were treated with
tocopherol derivatives, were removed 48 hours after UV exposure.
The thickness of the skin was measured at three midline sites using a
caliper (Digimatic Micrometer 543; Mitutoyo Co., Tokyo, Japan) that
was accurate to 0.01 mm.
Determination of c-Toc, a-Toc, and c-CEHC concentrations
in skin
Skin samples (100 mg wet weight) were homogenized at 41C in 1 ml
of 200 mM Tris-HCl buffer (pH 7.0). using a Polytron system
(Kinematica CH-1600, Littau-Lucerne, Switzerland). a-Toc and
g-Toc, and their derivatives were analyzed using a previously
described HPLC method (Nakayama et al., 2003), with some
modifications. The analyses were performed using an HPLC system
SCL-10A (Shimadzu Co., Kyoto, Japan) in combination with UV/VIS
(SPD-10A) and fluorescence (RF-535) HPLC monitors (Shimadzu
Co., Kyoto, Japan). The fluorescence absorbance for a-Toc and g-Toc
was monitored at an excitation wavelength of 296 nm and an
emission wavelength of 323 nm; the UV absorbance of their
derivatives was monitored at a wavelength of 285 nm.
g-CEHC in g-TDMG concentrations were determined by HPLC
as previously described (Hattori et al., 2001). g-CEHC in skin
homogenates was derivatized with a fluorescent reagent, 4-N,
N-dimethylaminosulfonyl-7-piperazino-2,1,3-benzoxadiazole, and
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acetylated with acetyl chloride after deproteinization with adding
CH3CN-EtOH (4:1, V/V). Following purification using an Empore-
TMC18 cartridge, the sample was injected into the column switching
HPLC system. Detection was carried out fluorometrically at 560 nm
after excitation at a 450 nm wavelength.
PGE2 assay
Skin samples (150 mg wet weight) were removed 24 hours after UV
exposure and frozen in liquid nitrogen, after which they were
crushed in a mortar and then homogenized on dry ice in 4 ml
of buffer containing 50 mM Tris-HCl and 0.25% sucrose (pH 8.3)
using a Dounce homogenizer; the samples were then centrifuged at
8,000 g, at 41C for 20 minutes. The supernatants were again
centrifuged at 100,000 g for 20 minutes at 41C and after which the
pellets were dissolved in 200 ml of 50 mM potassium phosphate buffer
(pH 7.4) containing 1 mM phenol. PGE2 concentrations were
measured in the dissolved pellets by a PGE2 ELISA kit from Cayman
Chemicals (MI) according to the manufacture’s instructions.
COX-2 activity assay
Our COX activity assay was based on the measurement of the
peroxidase component of cyclooxygenase. Peroxidase activity was
assessed colorimetrically by quantifying the levels of oxidized
N,N,N’,N’-tetramethyl-p-phenylenediamineat 590 nm. Hydroperoxi-
dase activity was determined by spectrophotometry. Skin samples
(400 mg wet weight) were prepared as described above for the
PGE2 and 50ml of supernatants from the centrifuged homogenates
(8,000 g for 20 minutes) were added into the reaction mixture
(COX-1 assay kit, Cayman Chemical; MI) that contained 100ml
of assay buffer, 10ml of heme, 20ml of N,N,N’,N’-tetramethyl-p-
phenylenediamine and inhibitory test compounds. Reactions were
initiated by the addition of 20ml of arachidonic acid to the mixture
after which changes in absorbance at 590 nm were measured.
Inhibitory activity was calculated by comparing the initial rate of
change in absorbance in the presence of test compounds with that
observed with the potent COX-2 inhibitor DuP-697 (5-bromo-[4-
fluorophenyl]-3-[4-(methylsulfonyl)phenyl] thiophene.
Nitrite determination
Skin samples (100–150 mg wet weight) were minced and homo-
genized in 10 volumes of 50 mM phosphate buffer, pH 7.8 at 21C,
using a Polytron homogenizer (Kinematica CH-1600, Littau-Lucerne,
Switzerland), after which the homogenates were centrifuged at
8,000 g for 20 minutes at 41C. The nitrite concentration in the
supernatants (80 ml) was measured as an indicator of NO production
using a fluorometric DAN (2,3-diaminonaphtalen) test kit (NO2
Assay Kit-F II, Dojindo Laboratories, Kumamoto, Japan) using
NaNO2 as the standard (Marzinzig et al., 1997).
RT-PCR analysis
Skin samples (100 mg wet weight) were removed 8 hours after UV
exposure, frozen and then crushed in a mortar on dry ice. Total RNA
was isolated from the crushed tissues by using guanidinium
isothocyanate and acid phenol/chloroform (Chomczynski and
Sacchi, 1987). Single-stranded cDNA was synthesized using a first-
strand cDNA synthesis kit (ReverTra Ace-a-TM, TOYOBO Co. Ltd,
Osaka, Japan). PCR was performed in 5ml of PCR buffer, 1ml
of dNTP mixture, 4ml of sterilized distilled water, 1ml of primer, and
0.25ml of Takara Ex TaqTM (Takara Bio Inc., Otsu, Japan).
Amplification was initiated at 961C for 2 minutes, and subsequently
run for 60 seconds at 961C, 60 seconds at 631C, 120 seconds at 721C
for 25 cycles, followed by a final extension for 7 minutes at 721C.
Amplification of the iNOS gene was run for 35 cycles. The following
oligo-nucleotide primers were used: COX-2 (277 bp), 50-GCATTCT
TTGCCCAGCACTT-30 (forward primer), 50-AGACCAGGCACCAGA
CCAAAGA-30(reverse primer); iNOS (492 bp), 50-CAGTGCCCTGCT
TTGTGCGAAGT-30(forward primer), 50-AACGTTTCTGGCTCTTGA
GCTGGAA-30(reverse primer); glyceraldehyde-3-phosphate dehydro-
genase (262 bp), 50-AATGTATCCGTTGTGGATCT-30(forward primer),
50-TCCACCACCCTGTTGCTGTA-30(reverse primer). PCR products
were analyzed by 2% agarose gel electrophoresis. The size of the
products was identical to that predicted from the sequences. After
staining with ethidium bromide, the gels were viewed under UV
light, and digital images were captured with a CCD camera system.
Immunoblot analysis
Skin samples (200 mg wet weight) were removed 24 hours after UV
exposure, frozen and then crushed in a mortar on dry ice and then
homogenized on dry ice in 4 ml of buffer containing 50 mM Tris-HCl
and 0.25% sucrose (pH 8.3) using a Polytron homogenizer;
the homogenate was then centrifuged at 8,000 g, at 41C for
20 minutes. Supernatants were extracted with a lysis buffer contain-
ing of 0.25 M Tris-HCl (pH 7.5), 0.375 M NaCl, 1.12% diethyldithio-
carbonate, 0.02% phenylmethyl sulfonyl fluoride, and 1% Tween
20. The lysates (B40 mg protein) were separated in 7% polyacryla-
mide gel by SDS-PAGE and transferred onto polyvinylidene
difluoride membranes. The membranes were then blocked with
5% nonfat-dried milk in tris-buffered saline-T buffer consisting
150 mM NaCl, 50 mM Tris-HCl (pH 7.5), and 0.05% Tween 20, after
which they were incubated with anti-COX-2 (murine, polyclonal
antibody, Cayman Chemical; 1:1500) or anti-actin (Cayman
Chemical; 1:3000) antibodies for 40 hours at 41C. After several
washes with water and tris-buffered saline-T, the membranes were
incubated with alkaline phosphatase-conjugated secondary anti-
bodies (British BioCell International Ltd, UK; 1:3000) for 3–4 hours at
room temperature. Following several washes with water and tris-
buffered saline-T at pH 9.5, the blots were incubated with CDP-Star
chemiluminescent substrate (New England Biolabs, UK). Chemilu-
minescent signal was detected with FP-3000B instant film (Fujifilm,
Tokyo, Japan) using ECL minicamera (GE Healthcare Bio-Sciences
Co., NJ).
Lipid peroxidation
Skin samples were homogenized in 10 volumes of 50 mM phosphate
buffer, pH 7.8 at 21C, using a Polytron homogenizer. Lipid
peroxidation was measured in these homogenates using a thiobarbi-
turic acid reactive substances assay (Kikukawa et al., 1992). The
concentration of thiobarbituric acid reactive substance was
expressed per mg protein, the latter of which was determined using
the Bradford method with bovine plasma globulin as the standard.
Statistics
Data are expressed as the mean7SE. Differences between groups
were assessed using a one-way analysis of variance followed by
Bonferroni-corrected t-tests. Differences of Po0.05 were considered
to be statistically significant.
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